|
Volumn 21, Issue 6, 2015, Pages 795-796
|
The sum of all browning in FGF21 therapeutics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBROBLAST GROWTH FACTOR 21;
UNCOUPLING PROTEIN 1;
ANTIOBESITY AGENT;
FIBROBLAST GROWTH FACTOR;
ADIPOCYTE;
ANTIDIABETIC ACTIVITY;
ARTICLE;
BLOOD BRAIN BARRIER;
BROWN ADIPOSE TISSUE;
DIABETES MELLITUS;
DYSLIPIDEMIA;
ENERGY EXPENDITURE;
FATTY LIVER;
FOOD INTAKE;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
PROTEIN INDUCTION;
THERAPY;
THERMOGENESIS;
WEIGHT REDUCTION;
WHITE ADIPOSE TISSUE;
ANIMAL;
DRUG EFFECTS;
MALE;
ADIPOSE TISSUE, WHITE;
ANIMALS;
ANTI-OBESITY AGENTS;
FIBROBLAST GROWTH FACTORS;
MALE;
OBESITY;
|
EID: 84930587228
PISSN: 15504131
EISSN: 19327420
Source Type: Journal
DOI: 10.1016/j.cmet.2015.05.018 Document Type: Short Survey |
Times cited : (13)
|
References (10)
|